News Articles on Valeant Pharmaceuticals International

Valeant Pharmaceuticals Highlights Taribavirin Phase IIb End of Study Data Presentation at American Association for the Study of Liver Disease (AASLD) Annual Meeting

ALISO VIEJO, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals (NYSE: VRX) today announced that results from the week-72 ana
http://www.bioportfolio.com/news/Valeant-Pharmaceuticals-Highlights-Taribavirin.html - Tuesday November 3 2009

Valeant Pharmaceuticals Reports Third Quarter Financial Results

ALISO VIEJO, Calif., Nov. 2 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced
http://www.bioportfolio.com/news/Valeant-Pharmaceuticals-Reports-Third-Quarter.html - Monday November 2 2009

Valeant to Acquire Polish Products

ALISO VIEJO, Calif., Oct. 30 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced that it ha
http://www.bioportfolio.com/news/Valeant-to-Acquire-Polish.html - Friday October 30 2009

Valeant Pharmaceuticals to Announce 2009 Third Quarter Results on November 2, 2009

ALISO VIEJO, Calif., Oct. 23 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced that it wi
http://www.bioportfolio.com/news/Valeant-Pharmaceuticals-to-Announce-2009-Third.html - Friday October 23 2009

Valeant to Acquire Major Australian Skincare Brands

ALISO VIEJO, Calif., Sept. 30 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE
http://www.bioportfolio.com/news/Valeant_to_Acquire_Major_Australian_Skincare.html - Wednesday September 30 2009

Valeant Buys-Out Rights to All Current and Future Income and Milestone Obligations From Former Dow Stockholders

ALISO VIEJO, Calif., Sept. 29 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced that, for
http://www.bioportfolio.com/news/Valeant_Buys-Out_Rights_to_All_Current_and_Future.html - Tuesday September 29 2009

Valeant Pharmaceuticals to Present at Goldman Sachs 30th Annual Global Healthcare Conference

ALISO VIEJO, Calif., June 2 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced that J. Michael Pearson, th
http://www.bioportfolio.com/news/Valeant_Pharmaceuticals_to_Present_at_Goldman.html - Tuesday June 2 2009

Valeant Pharmaceuticals Reports Encouraging Final Results With Taribavirin Phase IIb Study

ALISO VIEJO, Calif., June 1 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) today rep
http://www.bioportfolio.com/news/Valeant_Pharmaceuticals_Reports_Encouraging_Final.html - Monday June 1 2009

Valeant Grants Schering-Plough Exclusive Option in Japan for Taribavirin in Exchange for Release of Last Right of Refusal

ALISO VIEJO, Calif., June 1 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) announced today that it has entered into an
http://www.bioportfolio.com/news/Valeant_Grants_Schering-Plough_Exclusive_Option.html - Monday June 1 2009

Valeant Announces Increase to Securities Repurchase Program

ALISO VIEJO, Calif., May 28 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) announced today that its board of directors
http://www.bioportfolio.com/news/Valeant_Announces_Increase_to_Securities.html - Thursday May 28 2009

Valeant Plans Senior Notes Offering

ALISO VIEJO, Calif., May 28 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) announced today its plans to offer $
http://www.bioportfolio.com/news/Valeant_Plans_Senior_Notes.html - Thursday May 28 2009

Valeant Pharmaceuticals to Webcast 2009 Annual Meeting of Stockholders

ALISO VIEJO, Calif., May 11 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced that it will conduct a live
http://www.bioportfolio.com/news/Valeant_Pharmaceuticals_to_Webcast_2009_Annual.html - Monday May 11 2009

Valeant to Acquire Polish Dermatology Company

ALISO VIEJO, Calif., May 8 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) announced that it has acquired EMO-FARM Ltd.
http://www.bioportfolio.com/news/Valeant_to_Acquire_Polish_Dermatology.html - Friday May 8 2009

Valeant Pharmaceuticals Reports First Quarter Financial Results

- Revenue up 17%, 36% at constant exchange rates

- GAAP EPS $0.37, adjusted Cash EPS $0.46http://www.bioportfolio.com/news/Valeant_Pharmaceuticals_Reports_First_Quarter.html - Tuesday May 5 2009

Valeant Pharmaceuticals to Present at Bank of America and Merrill Lynch 2009 Health Care Conference

ALISO VIEJO, Calif., May 1 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced members of its senior manage
http://www.bioportfolio.com/news/Valeant_Pharmaceuticals_to_Present_at_Bank_of.html - Friday May 1 2009

Valeant Pharmaceuticals Highlights Taribavirin Phase IIb 60-Week Data Presentation at European Association for the Study of Liver (EASL) Annual Meeting

ALISO VIEJO, Calif., April 23 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals (NYSE: VRX) today announced that results from the week-60 analysis
http://www.bioportfolio.com/news/Valeant_Pharmaceuticals_Highlights_Taribavirin.html - Thursday April 23 2009

Valeant Pharmaceuticals to Announce 2009 First Quarter Results on May 5, 2009

ALISO VIEJO, Calif., April 23 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced that it will host a confe
http://www.bioportfolio.com/news/Valeant_Pharmaceuticals_to_Announce_2009_First.html - Thursday April 23 2009

Valeant Pharmaceuticals Appoints Steve Stefano of GlaxoSmithKline to Fill Board Vacancy

ALISO VIEJO, Calif., March 31 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced the appointment of Steve
http://www.bioportfolio.com/news/Valeant_Pharmaceuticals_Appoints_Steve_Stefano_of.html - Tuesday March 31 2009

Valeant Pharmaceuticals Appoints President of Valeant Pharmaceuticals International

ALISO VIEJO, Calif., March 19 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals (NYSE: VRX) today announced that it has appointed Dr. Bhaskar Chaud
http://www.bioportfolio.com/news/Valeant_Pharmaceuticals_Appoints_President_of.html - Thursday March 19 2009

Valeant Pharmaceuticals to Present at Cowen and Company 29th Annual Health Care Conference

ALISO VIEJO, Calif., March 11 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced members of its senior man
http://www.bioportfolio.com/news/Valeant_Pharmaceuticals_to_Present_at_Cowen_and.html - Wednesday March 11 2009

Acanya(TM) Gel, a New Treatment for Moderate to Severe Acne, Launched by Coria Laboratories

Expanded Dermatology Division of Valeant Pharmaceuticals Introduces Fixed Combination Acne Treatment Designed to Increase Patient Satisfaction
http://www.bioportfolio.com/news/Acanya%28TM%29_Gel%2C_a_New_Treatment_for_Moderate_to.html - Friday March 6 2009

Coria Laboratories Announces Acanya(TM) Gel Data Presentations at 67th American Academy of Dermatology Annual Meeting

FORT WORTH, Texas, Feb. 26 /PRNewswire-FirstCall/ -- Coria Laboratories, the newly expanded dermatology division of Valeant Pharmaceuticals Int
http://www.bioportfolio.com/news/Coria_Laboratories_Announces_Acanya%28TM%29_Gel_Data.html - Thursday February 26 2009

Valeant Pharmaceuticals Reports Fourth Quarter and Full Year Financial Results

ALISO VIEJO, Calif., Feb. 24 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced fourth quarter and ful
http://www.bioportfolio.com/news/Valeant_Pharmaceuticals_Reports_Fourth_Quarter.html - Tuesday February 24 2009

Valeant Pharmaceuticals to Announce 2008 Fourth Quarter and Year Results on February 24, 2009

ALISO VIEJO, Calif., Feb. 11 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced that it will host a confer
http://www.bioportfolio.com/news/Valeant_Pharmaceuticals_to_Announce_2008_Fourth.html - Wednesday February 11 2009

Valeant Pharmaceuticals to Present at Roth 21st Annual OC Growth Stock Conference

ALISO VIEJO, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced members of its senior manag
http://www.bioportfolio.com/news/Valeant_Pharmaceuticals_to_Present_at_Roth_21st.html - Thursday February 5 2009

Valeant Pharmaceuticals Appoints Anders Lonner of Meda to Fill Board Vacancy

ALISO VIEJO, Calif., Jan. 13 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced the appointment of Anders
http://www.bioportfolio.com/news/Valeant_Pharmaceuticals_Appoints_Anders_Lonner_of.html - Tuesday January 13 2009

Valeant Pharmaceuticals Appoints Chief Operating Officer of Specialty Pharmaceuticals

ALISO VIEJO, Calif., Jan. 6 /PRNewswire-FirstCall/ --Valeant Pharmaceuticals International (NYSE: VRX) today announced that it has appointed Rajiv
http://www.bioportfolio.com/news/Valeant_Pharmaceuticals_Appoints_Chief_Operating.html - Tuesday January 6 2009

Valeant Pharmaceuticals to Present at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top

ALISO VIEJO, Calif., Dec. 24 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced members of its senior
http://www.bioportfolio.com/news/Valeant_Pharmaceuticals_to_Present_at_Goldman.html - Wednesday December 24 2008